APREA THERAPEUTICS INC (APRE) Stock Cash Flow
NASDAQ:APRE • US03836J2015
Current stock price
0.68 USD
+0.01 (+1.49%)
Last:
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.04M | -12.96M | -14.29M | -112.66M | -37.13M | |||
| Depreciation Amortization | 18.60K | 22.30K | 7.10K | 0.00 | 10.00K | |||
| Change In Working Capital | -966.60K | -1.06M | 1.62M | -1.76M | -8.33M | |||
| Other non cash items | 540.80K | 435.10K | 483.40K | 89.41M | 7.76M | |||
| OPERATING CASH FLOW | -13.49M | -13.56M | -12.18M | -25.01M | -37.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -15.50K | -93.10K | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | N/A | -15.50K | -93.10K | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 974.80K | 16.14M | 5.79M | 680.00K | 1.75M | |||
| Other Financing Activity | -44.20K | -1.32M | -648.90K | N/A | N/A | |||
| FINANCING CASH FLOW | 620.60K | 14.82M | 5.14M | 680.00K | 1.75M | |||
| Exchange Rate Effect | -23.80K | -7.20K | -8.40K | 40.00K | 0.00 | |||
| CHANGE IN CASH | -12.89M | 1.24M | -7.14M | -24.29M | -35.94M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.49M | -13.56M | -12.18M | -25.01M | -37.69M | |||
| Capital Expenditure | N/A | -15.50K | -93.10K | 0.00 | 0.00 | |||
| FREE CASH FLOW | -13.49M | -13.57M | -12.27M | -25.01M | -37.69M | |||
All data in USD